Drug Search Results
More Filters [+]

PG-201

Alternative Names: pg-201, pg201, pg 201
Latest Update: 2012-04-12
Latest Update Note: Clinical Trial Update

Product Description

For Osteoarthritis of the Knee

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Asahi Kasei Pharma
Company Location: TOKYO M0 1018101
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for PG-201

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Osteoarthritis, Knee

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

PG201-P3

P3

Completed

Osteoarthritis, Knee

2011-03-01

PG201-PT-001

P2

Completed

Osteoarthritis, Knee

2009-09-01

Recent News Events

Date

Type

Title